Chronic consumption of a high-fat, refined carbohydrate (HFS) diet causes hypertension.
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In a series of recent studies, we have documented that a high-fat, refinedcarbohydrate diet (HFS), one similar to that consumed in Westernized societies, induces insulin resistance (1) , endothelial dysfunction (25) and other characteristics of the metabolic syndrome. We have also shown that prolonged HFS diet consumption results in hypertension, which is accompanied by enhanced vascular NO inactivation in genetically normotensive Fischer rats (30) .
Increased dietary salt intake raises arterial pressure in salt-sensitive, but not in saltresistant humans (10) and animals (21, 22) . The mechanism(s) to explain why salt sensitivity occurs in some animals, but not others is unclear. Tolins and Shultz (38) documented that high-salt feeding induces an increase in NO production and enhances natriuresis without raising blood pressure in genetically normotensive Spague-Dawley rats. However, in the presence of a NOS inhibitor, increased dietary salt intake results in a rise in blood pressure which helps restore sodium balance via pressure natriuresis.
Similarly, others have found either no significant change or a mild rise in blood pressure with salt loading in genetically normotensive animals (18, 23 ). An earlier study by our group demonstrated that salt-sensitivity in Dahl salt-sensitive rats may be linked to downregulation of renal and vascular NOS expression (21) . As reviewed by Majid et al. (16) , tubuloglomerular feedback-mediated afferent arteriolar vasoconstrictive response to luminal sodium concentration is attenuated by NO-derived from nNOS in the macula densa. Moreover, pharmacologic inhibition of NOS has been shown to augment tubuloglomerular feedback response (16, 47) . In fact, inhibition of nNOS has been reported to confer salt sensitivity in experimental animals (47) . Based on evidence that insulin resistance is associated with salt-sensitivity in humans (11, 12) , diets that cause insulin resistance may also induce salt sensitivity. Since chronic consumption of a HFS 3 diet causes insulin resistance (1) and a functional NO deficiency (30), we hypothesized that it may lead to salt sensitivity and that diminished renal NO availability plays a role in conferring salt sensitivity in this model.
Methods

Animals and Diet
All protocols were conducted in accordance with the University of California, Los Angeles, Animal Research Committee. Two-month-old female Fischer rats were obtained from Harlan Sprague Dawley, Inc. (San Diego, CA). We have used this rat model in our previous studies, as the female Fischer rat normally shows little weight gain after its maturation phase (1, 30) . The animals (N=8 per group) were housed 4 per cage with a 12 h light cycle starting at 0700h at 75-76 °F and were allowed to acclimatize to their environment for 1 week before the dietary intervention was initiated. The animals were randomly assigned to either the LFCC or HFS diet and fed the diets and water ad libitum. We previously noted that both groups consume a similar number of calories (26) .
The diets were prepared in powder form by Purina Test Diets Inc. (Richmond, IN) and contained a standard vitamin and mineral mix and all essential nutrients. The LFCC diet (Purina 5001) is low in saturated fat and contains mostly complex carbohydrate (starch) while the HFS diet is high in saturated and monounsaturated fat (primarily from lard plus a small amount of corn oil) and high in refined-sugar (sucrose) as previously published (28) .
Prior to sacrifice at 2 years on the diets, animals from both groups were placed on a high salt (4.0%) diet for a period of 1 week while others were continued on the standard 0.4% diets. Blood pressure was measured by tail cuff plethysmography as previously described (30) . In brief, the rats were placed in a constant temperature (29°C) chamber 4 for at least 15 min on 2-3 separate days to acclimate them to the chamber environment.
Subsequently, several recordings were made while the animals were quietly resting.
During the initial experiments blood pressure was measured on 2 days, and if recordings are not similar then measurements are taken on a third day. The daily means from 5-6 viable measurements were calculated to get a value for each rat.
Urinary NO Metabolite Excretion
Urinary excretion of the total nitrite and nitrate (NO x ) was determined subsequent to the rats being placed in metabolic chambers and fasted for 2 days during urine collection as previously described (30) .
Nitrotyrosine Measurement
Renal tissue (25% w/v) was homogenized in a solution containing 50 mM Tris-HCl (pH 7.4); 1% NP-40; 0.25% sodium deoxycholate; 150 mM NaCl; 1 mM EGTA; aprotinin, leupeptin, pepstatin (1 µg/ml each); 1 mM Na 3 VO 4 ; and 1 mM NaF at 0-4°C using a polytron homogenizer. Homogenates were centrifuged at 12,000 G at 4°C for 5 minutes to remove tissue debris and nuclear fragments. The supernatant was processed for determination of total protein concentration by a BCA protein assay kit (Pierce Inc., Rockford, Illinois, USA) and tissue nitrotyrosine abundance was determined by Western blot as previously described (40) using an anti-nitrotyrosine monoclonal antibody (Upstate Biotechnology Inc., Lake Placid, New York, USA).
Nitric Oxide Synthase Protein Determination
Western blotting was performed on renal tissues of both groups at 2 years to quantify eNOS, iNOS and nNOS protein levels using anti-eNOS, anti-iNOS and anti-nNOS monoclonal antibodies (Transduction Laboratories, Lexington, Kentucky) as previously described (42). 5 
Statistical Analysis
Statistical analyses were performed with Graph Pad Prism (GraphPad, San Diego, CA). Data were analyzed using an ANOVA when comparing more than 2 groups and a t-test when comparing 2 groups. When significant F values were noted, post hoc analyses were performed using a Newman-Keuls Multiple Comparison Test. Differences were considered statistically significant at P<0.05. Values reported are means ± SE with 7-8 rats per group unless otherwise indicated.
Results
Blood Pressure, Body Weight
The HFS group exhibited a gradual rise in systolic blood pressure during the 2 year study period (P<0.008, ANOVA). In contrast, blood pressure remained unchanged in the LFCC control group throughout the course of the study (blood pressure at 2 years: 147.3±3.7 vs. 123.0±3.9 mm Hg, P<0.01, Figure 1 ). The HFS group weighed significantly more than the LFCC group (374.0±9.0 vs. 260.0±6.0 g, P<0.001) Blood pressure increased significantly in the HFS rats after 1 week of high-salt feeding (160.0±4.1 vs. 147.3±3.7 mm Hg). In contrast, the high-salt diet had no effect on blood pressure in the LFCC rats (123.8±4.8 vs. 123.0±3.9 mm Hg, Figure 1 ).
Renal Nitrotyrosine, eNOS, iNOS, and nNOS Protein Abundance and Urinary NO x Excretion
Compared with the LFCC, the HFS animals exhibited a marked increase in renal nitrotyrosine abundance (Figure 2 ). This was accompanied by a significant reduction of renal nNOS protein abundance (Figure 3 ) pointing to increased NO inactivation and decreased nNOS-derived NO production capacity in HFS-fed animals at 2 years. This was coupled with a compensatory upregulation of renal eNOS and iNOS proteins in the 6 HFS group (Figure 3) . In fact, long-term HFS diet consumption resulted in a marked reduction in urinary NO x excretion (540±170 vs. 10±10 µmoles/g creatinine) (Figure 3) pointing to reduced NO availability.
Discussion
HFS animals exhibited a marked increase in nitrotyrosine pointing to increased NO inactivation. This was accompanied by a significant reduction in urinary NO x excretion denoting reduced NO availability. To test the effect of diet and NO on salt sensitivity, salt loading studies were performed. After nearly 2 years on either the LFCC or HFS diet when hypertension had been induced in the HFS group, the rats were placed on a high-salt diet for 1 week by adding NaCl to the food for a final concentration of 4%. The reduction in NO availability in the HFS diet-fed animals was associated with marked salt sensitivity as evidenced by a significant rise in blood pressure on the high-salt diet. In contrast, the LFCC group exhibited resistance to the high-salt diet as evidenced by a lack of change in arterial pressure despite high-salt intake. These observations point to renal NO deficiency as a likely cause of salt sensitivity in the HFS animals.
Nitrotyrosine is the stable footprint of the interaction between NO, ROS and tyrosine residues of proteins, and as such, its accumulation in the renal tissue of animals with dietinduced hypertension reflects increased ROS-mediated NO inactivation in this model (9, 13) . Oxidation and sequestration of NO by ROS, such as superoxide decreases NO availability (2, 46) . In addition to inactivating NO, ROS and their byproduct of interaction with NO, peroxynitrite, can oxidize and deplete tetrahydrobiopterin, an essential NOS cofactor which can augment NO deficiency and oxidative stress by uncoupling NOS from a NO producing to a superoxide producing enzyme (3). Along Increased production of NO results in renal vasodilation and both natriuresis and diuresis. A defect in the production of NO might be responsible for the salt-sensitivity found in many hypertensive patients (4). Administration of competitive NOS inhibitors reduces sodium excretion and increases renovascular resistance (15, 24) . In the normotensive animal, dietary sodium loading results in increased NO production (as demonstrated by an increase in NO metabolite excretion) which facilitates natriuresis and preserves blood pressure homeostasis (6, 35) . Furthermore, Chen and Sanders (5) showed that increases in dietary salt increased NO production in salt-resistant but not salt-sensitive Dahl rats, suggesting that decreased NO production may cause saltsensitive hypertension. It appears that in the presence of defective NO metabolism, an increase in blood pressure is necessary to maintain sodium balance. Furthermore, when the NO system is intact, increases in dietary sodium do not increase blood pressure. Data showing that rats which are resistant to the effects of salt become salt-sensitive in the presence of a NOS inhibitor supports this contention (38) . Long-term HFS diet consumption induced a marked reduction in renal nNOS abundance, which may have contributed to the salt sensitivity noted in this model. In the kidney, nNOS is prominently expressed in the macula densa and to a lesser extent in the efferent arteriole, mesangial cells and intrarenal neurons (16) . NO produced by macula densa attenuates tubuloglomerular feedback-mediated afferent arteriolar vasoconstriction in response to the luminal salt content (37, 47) . Thus, down-regulation of renal nNOS, ROS-mediated inactivation of NO or pharmacological inhibition of NOS can promote salt sensitivity. In 8 contrast to the control group which showed no discernable rise in blood pressure on the high-salt diet, the HFS group exhibited a marked rise in blood pressure with increased dietary salt intake pointing to an acquired salt sensitivity, mediated, at least in part, by a reduction in renal nNOS abundance and increased ROS-mediated NO inactivation. This NO deficiency would result in an exaggerated tubuloglomerular feedback response leading to salt retention, volume expansion, increased renovascular resistance and hypertension. Thus, it appears that the NO deficiency in the HFS may have contributed to the salt-sensitivity in this group.
Human studies also suggest that there is a variation in the blood pressure response to dietary sodium, with some individuals being salt-sensitive and others salt-resistant. While approximately 25% of normotensive individuals exhibit an increase in blood pressure with salt loading more than 50% of hypertensive patients experience a blood pressure rise in response to salt loading (45) . In addition, several investigators have reported a relationship between insulin resistance and salt sensitivity. Rocchini et al. (31) and Sharma et al. (32, 33) demonstrated that sodium-resistant individuals were more insulinsensitive. It has been established that high-salt feeding is associated with insulin resistance and a blunted NO generation in humans (10) . Along these lines, the HFS animals in the present study exhibited insulin resistance (28) and thus salt sensitivity may be an additional manifestation of diet-induced syndrome X.
In contrast to nNOS which was significantly decreased, eNOS and iNOS were elevated. An upregulation of eNOS and iNOS has been demonstrated in other models of hypertension (39, 41) . This is primarily due to avid inactivation of NO by ROS and the resultant attenuation of the negative feedback regulatory influence of NO on NOS expression (43) . In fact, the abundance of nitrotyrosine, which is the byproduct of NO-9 ROS-tyrosine interaction was elevated in the HFS group as well as in various other forms of hypertension (44) . Thus, despite upregulation of iNOS and eNOS the biovailability of NO is in fact diminished in this model. To our knowledge there is only one other study that has also investigated the role of a high-fat diet on NOS isotype expression. Using a diet containing 32% of energy from fat, Dobrian et al. (8) reported the occurrence of obesity, hypertension, oxidative stress and and compensatory upregulation of renal eNOS mRNA in a subgroup of rats designated as obesity-prone. The HFS diet employed in the present study contained a higher fat content (39%) than that used by Dobrian et al. In addition, the fat used in the present study was primarily saturated in nature, whereas the type of fat used by Dobrian et al. (8) was not specified. Moreover, in our study, the HFS diet included sucrose as its main carbohydrate source, which may further contribute to the observed abnormalities since high-sugar diets in the form of fructose have been shown to induce endothelial dysfunction (14) .
Although the role of eNOS in the regulation of cardiovascular function is well-characterized, the role of iNOS is less clear. It should be noted that contrary to the conventional view, iNOS is constitutively expressed in several tissues, such as heart, vascular smooth muscle and kidney (19, 20) . In the present study, iNOS expression was virtually undetectable in the LFCC and increased in the presence of HFS-diet consumption, suggesting the possibility of diet-induced inflammation.
The role of obesity in this model of diet-induced hypertension is unclear. It is well established that obesity is associated with hypertension and that reductions in blood pressure are associated with weight loss (7, 17) . The HFS group weighed significantly more than the LFCC group. While the reduction in body weight previously noted in this model after converting the animals from the HFS to the LFCC diet may have contributed 10 to the reductions in blood pressure and oxidative stress and the increase in NO availability, the animals still weighted significantly more (~45g) than the control group (29) . Recently we documented a large reduction in blood pressure in obese men using a 3-week intensive diet and exercise intervention, which occurred despite a modest change in BMI from 37.6 to 36.1, indicating the presence of significant obesity after the program (27) . Furthermore, in a recent study, intentional weight loss achieved by gastric surgery yielding a sustained weight loss of ~20 kg had no effect on the incidence of hypertension during an 8 year observation period (36) . Thus, the contributing role of obesity in this model requires further study, however it appears that the diet per se contributed to abnormalities noted in the present study.
Overall, prolonged consumption of the HFS diet induces excessive ROS production, which contributes to hypertension via NO inactivation and decreased NO availability (30) . Additionally, the HFS diet induces salt sensitivity which is associated with a reduction in renal nNOS expression further contributing to the development of hypertension by augmenting the tubulo-glomerular feedback response and diminishing pressure natriuresis. Thus, a HFS diet induces salt-sensitivity which is associated with and perhaps mediated, in part, by a renal NO deficiency. 
